Cellulær immunterapi ved cancer

Cellulær immunterapi ved cancer

Klinisk Immunologi

Cellular immunotherapy of cancer

The field of immunotherapy is currently one of the most promising developments in medical science now helping thousands of patients with cancer or autoimmune diseases. At KIA we have recently established a group engaging in the development of new ways to make the patient’s T cells capable of killing cancer cells and curing the patient. We use the chimeric antigen-receptor T cells (CAR T cells) method. The group works in close collaboration with the Morten Gjerstorff group at IMM, SDU, and with professor Niels Abildgaard at the Dept. of Hematology, OUH. with one of the strongest groups in the field: the Marcela V. Maus group at Massachusetts’ General Hospital and Harvard University. Dr. Maus is adjunct professor at KIA.

 

Principal investigator

Professor Torben Barington
Clinical Immunology, SDU
Klinisk Immunologisk afd.
Odense Universitetshospital
J. B. Winsløws Vej 4, 5000 Odense

Members of the team

Maria Ormhøj, PhD student
Mike Barnkob, MD, research associate
Kristina Fruerlund Rasmussen, MD, research associate

Ongoing projects

Development of Chimeric Antigen Receptor T cells Targeting the B-cell Receptor Signaling Pathway.
Forbedring af effektiviteten af CAR T-celler dannet ud fra blodceller fra patienter med blodkræft.
   

Project options for students

CAR T cells to combat cancer

Vi samler statistik ved hjælp af cookies for at forbedre brugeroplevelsen. Læs mere om cookies

Acceptér cookies